
Amid fluctuating global trade cycles, the company initiated a full-scale digital cross-border strategy to restructure growth frameworks and capture emerging overseas opportunities. We renewed our U.S. FDA listing and acquired the ISO 9001:2015 Quality Management System certification, further standardizing operational workflows and elevating global product quality governance.